Review



½ mic  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    ATCC ½ mic
    Overview of the effects of endocrine disruptors on bacterial virulence reported in the literature.
    ½ Mic, supplied by ATCC, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/½ mic/product/ATCC
    Average 93 stars, based on 1 article reviews
    ½ mic - by Bioz Stars, 2025-03
    93/100 stars

    Images

    1) Product Images from "Effect of endocrine disruptors on bacterial virulence"

    Article Title: Effect of endocrine disruptors on bacterial virulence

    Journal: Frontiers in Cellular and Infection Microbiology

    doi: 10.3389/fcimb.2023.1292233

    Overview of the effects of endocrine disruptors on bacterial virulence reported in the literature.
    Figure Legend Snippet: Overview of the effects of endocrine disruptors on bacterial virulence reported in the literature.

    Techniques Used: Bacteria, Membrane, Permeability, Expressing, Infection, In Vivo, Cell Adhesion Assay, Cell Surface Hydrophobicity, Plasmid Preparation, Transformation Assay, Concentration Assay, Mutagenesis, In Vitro, Mouse Assay, Control, Activity Assay, Staining, Cytometry, Metabolic Assay



    Similar Products

    ½ mic  (ATCC)
    93
    ATCC ½ mic
    Overview of the effects of endocrine disruptors on bacterial virulence reported in the literature.
    ½ Mic, supplied by ATCC, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/½ mic/product/ATCC
    Average 93 stars, based on 1 article reviews
    ½ mic - by Bioz Stars, 2025-03
    93/100 stars
      Buy from Supplier

    94
    Cell Signaling Technology Inc anti cleaved caspase 7
    Analysis of cisplatin, resveratrol, and in combination to induce apoptosis in OC cells under normoxic and hypoxic conditions by flow cytometry and Western blot. A2780 cells were treated with cisplatin (CisPt) (5.9 µM), resveratrol (Res) (63 µM), and in the combination CisPt+Res (at the same concentrations) according to : Establishment of Hypoxic Culture Conditions and Experimental Outline. ( A ) Percentage of apoptotic cells; ( B ) percentage of necrotic cells; ( C ) representative histograms from apoptosis analysis in A2780 cells; ( D – G ) Western blot analysis of cleaved <t>caspase-3,</t> <t>cleaved</t> <t>caspase-7,</t> and BAX protein expression. The graphs represent the densitometric analysis of the immunoblots. Vinculin was used as a loading control and normalized to the normoxia control as 1. The results shown are the mean ± SEM of three independent experiments, with *** p < 0.001, ** p < 0.01, * p < 0.05, vs. normoxia control (black asterisk) and vs. hypoxia control (grey asterisk); $$$ p < 0.001, $$ p < 0.01, $ p < 0.05 comparing the normoxia group with the hypoxia group; and ### p < 0.001, CisPt alone vs. CisPt+Res.
    Anti Cleaved Caspase 7, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti cleaved caspase 7/product/Cell Signaling Technology Inc
    Average 94 stars, based on 1 article reviews
    anti cleaved caspase 7 - by Bioz Stars, 2025-03
    94/100 stars
      Buy from Supplier

    93
    ATCC hexane extract ic 50
    Reports of in vitro and in vivo effects of propolis from studies on gastric cancer performed in different countries.
    Hexane Extract Ic 50, supplied by ATCC, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/hexane extract ic 50/product/ATCC
    Average 93 stars, based on 1 article reviews
    hexane extract ic 50 - by Bioz Stars, 2025-03
    93/100 stars
      Buy from Supplier

    94
    Cell Signaling Technology Inc cleaved caspase 7
    Reports of in vitro and in vivo effects of propolis from studies on gastric cancer performed in different countries.
    Cleaved Caspase 7, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cleaved caspase 7/product/Cell Signaling Technology Inc
    Average 94 stars, based on 1 article reviews
    cleaved caspase 7 - by Bioz Stars, 2025-03
    94/100 stars
      Buy from Supplier

    93
    ATCC mcdb 105
    Reports of in vitro and in vivo effects of propolis from studies on gastric cancer performed in different countries.
    Mcdb 105, supplied by ATCC, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mcdb 105/product/ATCC
    Average 93 stars, based on 1 article reviews
    mcdb 105 - by Bioz Stars, 2025-03
    93/100 stars
      Buy from Supplier

    94
    Cell Signaling Technology Inc ranibizumab
    Demographic characteristics of all treatment‐naïve CRVO eyes commencing <t> ranibizumab </t> or aflibercept treatment 2014–2019.
    Ranibizumab, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ranibizumab/product/Cell Signaling Technology Inc
    Average 94 stars, based on 1 article reviews
    ranibizumab - by Bioz Stars, 2025-03
    94/100 stars
      Buy from Supplier

    86
    Extech Instruments 42542 infrared ir thermometer
    Demographic characteristics of all treatment‐naïve CRVO eyes commencing <t> ranibizumab </t> or aflibercept treatment 2014–2019.
    42542 Infrared Ir Thermometer, supplied by Extech Instruments, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/42542 infrared ir thermometer/product/Extech Instruments
    Average 86 stars, based on 1 article reviews
    42542 infrared ir thermometer - by Bioz Stars, 2025-03
    86/100 stars
      Buy from Supplier

    93
    ATCC age 42 5
    Demographic characteristics of all treatment‐naïve CRVO eyes commencing <t> ranibizumab </t> or aflibercept treatment 2014–2019.
    Age 42 5, supplied by ATCC, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/age 42 5/product/ATCC
    Average 93 stars, based on 1 article reviews
    age 42 5 - by Bioz Stars, 2025-03
    93/100 stars
      Buy from Supplier

    Image Search Results


    Overview of the effects of endocrine disruptors on bacterial virulence reported in the literature.

    Journal: Frontiers in Cellular and Infection Microbiology

    Article Title: Effect of endocrine disruptors on bacterial virulence

    doi: 10.3389/fcimb.2023.1292233

    Figure Lengend Snippet: Overview of the effects of endocrine disruptors on bacterial virulence reported in the literature.

    Article Snippet: , Streptococcus mutans ATCC 25175 Streptococcus mutans ATCC 35668 , Exposure to TCS at ½ MIC, ¼ MIC during biofilm formation Adhesion assay on human gingival epithelial cell line OBA-9 of S. mutans cultures exposed to TCS (1/2, 1/4 or 1/8 MIC) Gene expression atlA , gtfC , gtfB comD luxS , assessed by RT-qPCR after 2h exposure to TCS (1/2, 1/4 or 1/8 MIC) , • TCS increased biofilm formation in S. mutans • At ½ MIC and ¼ MIC TCS, the biofilm is thicker with aggregates and microcolonies • At ½ MIC (42.5%) and ¼ MIC TCS, adhesion of ATCC 25175 is enhanced on OBA-9. No significative effect on cell surface hydrophobicity • Increased expression of gene involved adhesion and biofilm at TCS sub inhibitory concentrations , ( ) .

    Techniques: Bacteria, Membrane, Permeability, Expressing, Infection, In Vivo, Cell Adhesion Assay, Cell Surface Hydrophobicity, Plasmid Preparation, Transformation Assay, Concentration Assay, Mutagenesis, In Vitro, Mouse Assay, Control, Activity Assay, Staining, Cytometry, Metabolic Assay

    Analysis of cisplatin, resveratrol, and in combination to induce apoptosis in OC cells under normoxic and hypoxic conditions by flow cytometry and Western blot. A2780 cells were treated with cisplatin (CisPt) (5.9 µM), resveratrol (Res) (63 µM), and in the combination CisPt+Res (at the same concentrations) according to : Establishment of Hypoxic Culture Conditions and Experimental Outline. ( A ) Percentage of apoptotic cells; ( B ) percentage of necrotic cells; ( C ) representative histograms from apoptosis analysis in A2780 cells; ( D – G ) Western blot analysis of cleaved caspase-3, cleaved caspase-7, and BAX protein expression. The graphs represent the densitometric analysis of the immunoblots. Vinculin was used as a loading control and normalized to the normoxia control as 1. The results shown are the mean ± SEM of three independent experiments, with *** p < 0.001, ** p < 0.01, * p < 0.05, vs. normoxia control (black asterisk) and vs. hypoxia control (grey asterisk); $$$ p < 0.001, $$ p < 0.01, $ p < 0.05 comparing the normoxia group with the hypoxia group; and ### p < 0.001, CisPt alone vs. CisPt+Res.

    Journal: International Journal of Molecular Sciences

    Article Title: Hypoxia, but Not Normoxia, Reduces Effects of Resveratrol on Cisplatin Treatment in A2780 Ovarian Cancer Cells: A Challenge for Resveratrol Use in Anticancer Adjuvant Cisplatin Therapy

    doi: 10.3390/ijms24065715

    Figure Lengend Snippet: Analysis of cisplatin, resveratrol, and in combination to induce apoptosis in OC cells under normoxic and hypoxic conditions by flow cytometry and Western blot. A2780 cells were treated with cisplatin (CisPt) (5.9 µM), resveratrol (Res) (63 µM), and in the combination CisPt+Res (at the same concentrations) according to : Establishment of Hypoxic Culture Conditions and Experimental Outline. ( A ) Percentage of apoptotic cells; ( B ) percentage of necrotic cells; ( C ) representative histograms from apoptosis analysis in A2780 cells; ( D – G ) Western blot analysis of cleaved caspase-3, cleaved caspase-7, and BAX protein expression. The graphs represent the densitometric analysis of the immunoblots. Vinculin was used as a loading control and normalized to the normoxia control as 1. The results shown are the mean ± SEM of three independent experiments, with *** p < 0.001, ** p < 0.01, * p < 0.05, vs. normoxia control (black asterisk) and vs. hypoxia control (grey asterisk); $$$ p < 0.001, $$ p < 0.01, $ p < 0.05 comparing the normoxia group with the hypoxia group; and ### p < 0.001, CisPt alone vs. CisPt+Res.

    Article Snippet: After blocking, membranes were incubated overnight at 4 °C with: anti-cleaved caspase-3 (5A1E), anti-cleaved caspase-7 (D6H1), anti-caspase-3 (8G10), anti-caspase-7 (D2Q3L), anti-BAX (D2E11), anti-β-catenin (D10A8), anti-ZEB1 (D80D3), anti-vimentin (D21H3), anti-ZO-1 (all from Cell Signaling Technology, Danvers, MA, USA; isotype IgG), anti-HIF-1α (28b), anti-vinculin (V284), anti-SNAI1 (G-7), and anti-SNAI2 (A-7) antibodies (from Santa Cruz Biotechnology, Dallas, TX, USA; isotype IgG 1 kappa), followed by incubation with horse anti-mouse or goat anti-rabbit IgG secondary antibodies conjugated with horseradish peroxidase (1:10.000; Vector Laboratories, Burlingame, CA, USA) for 1 h at RT.

    Techniques: Flow Cytometry, Western Blot, Expressing

    Reports of in vitro and in vivo effects of propolis from studies on gastric cancer performed in different countries.

    Journal: Foods

    Article Title: The Role of Propolis as a Natural Product with Potential Gastric Cancer Treatment Properties: A Systematic Review

    doi: 10.3390/foods12020415

    Figure Lengend Snippet: Reports of in vitro and in vivo effects of propolis from studies on gastric cancer performed in different countries.

    Article Snippet: Thailand ( A. mellifera ) , -Cardanol -Cardol , Model: Gastric carcinoma KATO-III (ATCC No. HTB 103) cell line. Protocol: In vitro cytotoxic activity was assessed by the MTT method. A non-transformed human foreskin fibroblast cell line (Hs27, ATCC No. CRL 1634) was used for the comparison. Chemical analysis of the fractions by NMR and ESI-MS. , -Hexane extract IC 50 of 42.5 ± 6.61 μg/mL. -Dichloromethane extract IC 50 of 43.8 ± 6.5 μg/mL. -Fractions obtained from the hexane extract with cytotoxic activity: Fraction III IC 50 of 13.69 ± 1.44 μg/mL. Fraction IV IC 50 of 40.16 ± 2.66 μg/mL. Fraction V IC 50 of 15.21 ± 2.13 μg/mL. -Compounds identified in fractions III and V obtained from hexane extract: Cardanol (fraction III) IC 50 of 13.71 ± 1.42 μg/mL. Cardol (fraction V) IC 50 of 8.78 ± 0.28 μg/mL. , [ ] .

    Techniques: In Vitro, In Vivo, Activity Assay, Antioxidant Assay, Positive Control, Antioxidant Activity Assay, CCK-8 Assay, Permeability, Flow Cytometry, Western Blot, Microscopy, Activation Assay, Expressing, Staining, Immunohistochemistry, Cell Culture, Concentration Assay, TUNEL Assay, Mouse Assay

    Demographic characteristics of all treatment‐naïve CRVO eyes commencing  ranibizumab  or aflibercept treatment 2014–2019.

    Journal: Acta Ophthalmologica

    Article Title: 12‐month outcomes of ranibizumab versus aflibercept for macular oedema in central retinal vein occlusion: data from the FRB! registry

    doi: 10.1111/aos.15014

    Figure Lengend Snippet: Demographic characteristics of all treatment‐naïve CRVO eyes commencing ranibizumab or aflibercept treatment 2014–2019.

    Article Snippet: Baseline VA (SD) was somewhat better in aflibercept‐ versus ranibizumab‐treated eyes (42.5 ± 25.5 letters versus 36.9 ± 26 letters; p = 0.07) with similar CST (614 (240) μm versus 616 (234) μm: p = 0.95).

    Techniques:

    12‐month outcomes in all eyes and stratified by anti‐VEGF agent received. Significant p‐values comparing  ranibizumab  and aflibercept are highlighted in bold.

    Journal: Acta Ophthalmologica

    Article Title: 12‐month outcomes of ranibizumab versus aflibercept for macular oedema in central retinal vein occlusion: data from the FRB! registry

    doi: 10.1111/aos.15014

    Figure Lengend Snippet: 12‐month outcomes in all eyes and stratified by anti‐VEGF agent received. Significant p‐values comparing ranibizumab and aflibercept are highlighted in bold.

    Article Snippet: Baseline VA (SD) was somewhat better in aflibercept‐ versus ranibizumab‐treated eyes (42.5 ± 25.5 letters versus 36.9 ± 26 letters; p = 0.07) with similar CST (614 (240) μm versus 616 (234) μm: p = 0.95).

    Techniques: